Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Set To Grow From $50.29 Billion In 2026 To $62.82 Billion By 2030 At A CAGR Of 5.7%
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
The market for devices used in managing chronic obstructive pulmonary disease (COPD) and asthma has witnessed significant growth recently. With rising respiratory health challenges worldwide, demand for innovative and effective respiratory care solutions continues to expand. Let’s explore the current market size, growth drivers, major players, emerging trends, and regional dynamics shaping this important healthcare segment.
Market Size and Revenue Forecast for COPD and Asthma Devices
The COPD and asthma devices market has shown strong growth and is expected to continue expanding in the near term. Its market value is projected to rise from $47.56 billion in 2025 to $50.3 billion in 2026, representing a compound annual growth rate (CAGR) of 5.8%. Factors behind this growth historically include the increasing prevalence of asthma and COPD, worsening air pollution, higher smoking rates, wider adoption of inhalation therapies, the growth of respiratory care services, and enhanced diagnostic capabilities for chronic respiratory conditions.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18298&type=smp
Looking ahead, the market is forecasted to grow even more robustly, reaching $62.83 billion by 2030 with a CAGR of 5.7%. This anticipated expansion is driven by an aging global population more vulnerable to respiratory illnesses, rising demand for home-based respiratory care devices, growing awareness about early disease management, expansion of chronic disease programs, and improved access to respiratory care in emerging economies. Key trends shaping the market include increased adoption of home care respiratory devices, demand for portable and easy-to-use inhalers, a stronger focus on long-term disease management, growing use of devices among pediatric and elderly patients, and a heightened emphasis on treatment adherence and symptom control.
Key Factors Fueling Growth in the COPD and Asthma Devices Market
An important driver behind the COPD and asthma devices market is the rising incidence of respiratory diseases worldwide. These conditions, which include asthma, COPD, pneumonia, and lung cancer, affect lung function and breathing. The growing burden of respiratory diseases is linked to increased air pollution, climate change impacting allergens and pathogens, and lifestyle factors such as smoking that deteriorate respiratory health.
Access The Complete Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Report:
Devices designed for COPD and asthma management play a vital role in improving patient outcomes and quality of life. For example, in December 2023, the National Center for Biotechnology Information reported that the number of COPD cases in the U.S. is expected to increase by 112 million, reaching 592 million by 2050, which would account for 9.5% of the population at risk. This rising prevalence underscores the need for effective respiratory devices and continues to fuel market demand.
Detailed Segmentation of the COPD and Asthma Devices Market
This market is classified into several important segments to highlight growth opportunities:
1) By Type: Metered Dose Inhalers, Dry Powder Inhalers, Soft Mist Inhalers, Jet Nebulizers, Ultrasonic Nebulizers, and Other Device Types
2) By Indication: Asthma and Chronic Obstructive Pulmonary Disease
3) By Application: Hospitals, Clinics, Home Care Settings, Research Institutions, and Other Uses
4) By End User: Pediatric, Adult, and Geriatric Patients
Further subcategories include:
– Metered Dose Inhalers: Conventional and Breath-Actuated
– Dry Powder Inhalers: Single-Dose and Multi-Dose
– Soft Mist Inhalers: Respimat and Others
– Jet Nebulizers: Pneumatic and Venturi-Type
– Ultrasonic Nebulizers: Tabletop and Portable
– Other Types: Nebulizer Accessories and Spacer Devices
Innovative Trends Shaping the Future of COPD and Asthma Devices
Leading companies are investing in advanced, smart inhaler technologies to enhance patient care. These devices integrate sensors and digital connectivity to monitor medication adherence, track symptoms in real-time, and support personalized respiratory disease management.
For instance, in July 2023, UK-based Teva UK Ltd. introduced the GoResp Digihaler, a digitally connected inhaler that records inhalation data and offers real-time feedback. This technology enables remote monitoring, provides clinicians deeper insight into patient usage, and helps improve long-term disease management for those living with chronic respiratory conditions.
Key Players Driving Innovation and Competition in the COPD and Asthma Devices Market
The market features several prominent companies shaping its competitive landscape, including AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc, Boehringer Ingelheim, Royal Philips NV, Teva Pharmaceuticals Industries Ltd., Omron Corporation, Smiths Medical Inc., Cipla Ltd., Chiesi Farmaceutici SpA, Sunovion Pharmaceuticals Inc., Drive DeVilbiss Healthcare, Pari Respiratory Equipment Inc., Allied Healthcare Products Inc., Clement Clarke International Ltd., Cohero Health Inc., Pneuma Respiratory Inc., Mundipharma International Ltd., 3M Health Care, Vyaire Medical Inc., and Aerogen Ltd.
Geographical Insights and Regional Market Growth Patterns
As of 2025, North America holds the largest share of the COPD and asthma devices market. However, rapid growth is also expected in other regions, including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa. These regions represent significant opportunities due to rising respiratory health issues and expanding healthcare infrastructure.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
